Feb 02, 2022

UroLift Theater 2020

Treatment with the minimally invasive UroLift System delivers a proven patient experience with minimal reported side effects.

Anthony Herndon, MD

Protecting scientific integrity in the era of AI

Crossfire 01

Balancing risks and benefits of hydrodistension for IC/BPS

Tyson With Crowd

New intravesical therapies show promise in NMIBC trials

Prolapse Panel 03

U-POP and LUTD care refined in international consensus report

From left: Kymora Scotland, MD, PhD; Taylor Brewer, MSM, PA; and Greg Tasian, MD, MSc, MSCE.

New stone guidelines sharpen focus on patient-centered care

Jaspreet S. Sandhu, MD

Updated BPH guidelines focus on patients, not procedures

Jennifer Robles, MD, MPH

Antibiotic use clarified in stone removal guidelines

Ben H. Chew, MD, MSc

Break Wave challenges standard lithotripsy approach

Advocacy 02

Advocacy rewrites the label for HRT

Sara M. Lenherr, MD, MS, URPS

Reinventing one of urology’s oldest tools

H. Gilbert Welch, MD, MPH

The hidden cost of looking harder for cancer

Neal Shore, MD

Durvalumab + BCG continues to deliver in high-risk NMIBC